Role of NR2B-containing N-methyl-D-aspartate receptors in haloperidol-induced c-Fos expression in the striatum and nucleus accumbens

Neuroscience

Volumn 122, Issue 3, 2003, Pages 739-745

  Lee, J ^a   Rajakumar, N ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Dopamine; Glutamate; Immediate early genes; Neuroleptics; Schizophrenia

Indexed keywords

4 BENZYL ALPHA (4 HYDROXYPHENYL) BETA METHYL 1 PIPERIDINEPROPANOL; DIZOCILPINE; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PROTEIN C FOS; RACLOPRIDE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE SEVERITY; DOPAMINE RECEPTOR BLOCKING; DRUG BINDING SITE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; IMMEDIATE EARLY GENE; IMMUNOREACTIVITY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR INTRINSIC ACTIVITY; SCHIZOPHRENIA;

EID: 0242653685     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2003.08.019     Document Type: Article

References (27)

1. Boegman R.J., Vincent S.R. Involvement of adenosine and glutamate receptors in the induction of c-fos in the striatum by haloperidol. Synapse. 22:1996;70-77.
2. Cull-Candy S., Brickley S., Farrant M. NMDA receptor subunits diversity, development and disease . Curr Opin Neurobiol. 11:2001;327-335.
3. Deutch A.Y., Lee M.C., Iadarola M.J. Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression the nucleus accumbens shell as a locus of antipsychotic action . Mol Cell Neurosci. 3:1992;332-341.
4. Dragunow M., Robertson G.S., Faull R.L., Robertson H.A., Jansen K. D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience. 37:1990;287-294.
5. Fibiger H.C. Neuroanatomical targets of neuroleptic drugs as revealed by Fos immunochemistry. J Clin Psychiatry. 55:1994;SB33-35.
6. Fischer G., Mutel V., Trube G., Malherbe P., Kew J.N.C., Mohacsi E., Heitz M.P., Kemp J.A. Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit characterization in vitro . J Pharmacol Exp Ther. 283:1997;1285-1292.
7. Hussain N., Flummerfeldt B.A., Rajakumar N. Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens. Neuroscience. 102:2001;391-399.
8. Hurley K.M., Herbert H., Moga M.M., Saper C.B. Efferent projections of the infralimbic cortex of the rat. J Comp Neurol. 308:1991;249-276.
9. Joyce J.N., Loeschen K., Marshall J.F. Dopamine D-2 receptors in rat caudate-putamen the lateral to medial gradient does not correspond to dopaminergic innervation . Brain Res. 338:1985;209-218.
10. Keefe K.A., Adams A.C. Differential effects of N-methyl-D-aspartate receptor blockade on eticlopride-induced immediate early gene expression in the medial and lateral striatum. J Pharmacol Exp Ther. 287:1998;1076-1083.
11. Landwehrmeyer G.B., Standaert D.G., Testa C.M., Penney J.B. Jr, Young A.B. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J Neurosci. 15:1995;5297-5307.
12. Lynch D.R., Shim S., Seifert K.M., Kurapathi S., Mutel V., Gallagher M., Guttmann R.P. Pharmacological characterization of interactions of Ro 25-6981 with the NR2B (ε2) subunit. Eur J Pharmacol. 416:2001;185-195.
13. McGeorge A.J., Faull R.L. The organization of the projection form the cerebral cortex to the striatum in the rat. Neuroscience. 29:1989;503-537.
14. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B., Seeburg P. Heteromeric NMDA receptors molecular and functional distinction of subtypes . Science. 256:1992;1217-1221.
15. Moriyoshi K., Masu M., Ishii T., Shigemoto R., Mizuno N., Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature. 354:1991;31-37.
16. 3H]MK-801 binding to NMDA receptors in vivo and in vitro. Eur J Pharmacol. 397:2000;263-270.
17. 3H]Ro 25-6981, a potent and selective antagonist of NMDA receptors containing NR2B subunits. J Neurochem. 70:1998;2147-2155.
18. Nguyen T.V., Kosofsky B.E., Birnabaum R., Cohen B.M., Hyman S.E. Differential expression of c-Fos and Zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc Natl Acad Sci USA. 89:1992;4270-4274.
19. Paxinos G., Watson C. The rat brain in stereotaxic coordinates, 3rd edn. 1997;Academic, Sydney.
20. Rang H.P., Dale M.M. Neuroleptic drugs pharmacology . 1991;Churchill Livingstone, New York.
21. Robertson G.S., Fibiger H.C. Neuroleptics increase c-fos expression in the forebrain contrasting effects of haloperidol and clozapine . Neuroscience. 46:1992;315-328.
22. Robertson G.S., Vincent S.R., Fibiger H.C. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience. 49:1992;285-296.
23. Standaert D.G., Testa C.M., Young A.B., Penney J.B. Jr. Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J Comp Neurol. 343:1994;1-16.
24. Standaert D.G., Friberg I.K., Landwehrmeyer G.B., Young A.B., Penny J.B. Jr. Expression of NMDA glutamate receptor subunit mRNAs in neurochemically identified projection and interneurons in the striatum of the rat. Mol Brain Res. 64:1999;11-23.
25. Vinci S., Wang J.F., Li J.H., Zhu W.J., Wang Y.H., Luo J.H., Wolfe B.B., Grayson D.R. Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors. J. Neurophysiol. 79:1998;555-566.
26. Watanabe M., Inoue Y., Sakimura K., Mishina M. Distinct distributions of five of N-methyl-D-aspartate receptor channel subunit mRNAs in the forebrain. J Comp Neurol. 338:1993;377-390.
27. Ziolkowska B., Hollt V. The NMDA receptor antagonist MK-801 markedly reduces the induction of c-fos gene by haloperidol in the mouse striatum. Neurosci Lett. 156:1993;39-42.